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ABSTRACT                                                                                                                                                                                                             
Backgound: Tuberculosis as a state of chronic inflammation impacts on haematologic functions of the body. 
Objectives: This study aimed at assessing iron parameters and serum protein levels of ninety tuberculosis patients aged fifteen to sixty 
years, enrolled from Dr Lawrence Henshaw Memorial Hospital, Calabar, Nigeria. Ninety apparently healthy individuals age and gender-
matched served as control subjects.  
Methods: Packed cell volume, haemoglobin concentration, serum iron, total iron binding capacity, total protein, albumin and serum 
ferritin were determined using standard methods. Transferrin saturation, globulin concentration and albumin-globulin ratio were 
derived by calculation. Data were analysed using student T-test on SPSS version 20 software. Statistical significance was set at P-value 
less than 0.05.  
Results: Packed cell volume, haemoglobin concentration, serum iron, total iron binding capacity, transferrin saturation, albumin levels 
and albumin-globulin ratio of tuberculosis patients were found to be significantly lower while serum ferritin and globulin were 
significantly increased (p<0.05) as compared with control values. Serum ferritin improved towards control values as anti-tuberculosis 
therapy progressed.                                                                                                               
Conclusion: A reduction in haemoglobin, serum iron, total iron binding capacity and transferrin saturation and increase in serum 
ferritin as well as altered serum protein levels, occur in tuberculosis infection. 
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RÉSUMÉ                                                                                                                                                                                                                         
Fond : la tuberculose comme un état d'inflammation chronique hématologique des impacts sur les fonctions de l'organisme. 
Objectifs : Cette étude visait à évaluer les paramètres fer sérique et la teneur en protéines des quatre-vingt-dix patients âgés de 
quinze à soixante ans, inscrits par le Dr Lawrence Henshaw Memorial Hospital, Calabar Nigéria. Quatre-vingt-dix personnes 
apparemment en bonne santé appariés selon l'âge et le sexe ont servi de témoins. 
Méthodes : l'hématocrite, du taux d'hémoglobine, le fer sérique, capacité totale de fixation du fer, protéines totales, albumine et 
la ferritine sérique ont été déterminées en utilisant les méthodes standard. La saturation de la transferrine, l'albumine et 
globuline globuline concentration ratio ont été obtenus par calcul. Les données ont été analysées à l'aide de student T-test sur le 
logiciel SPSS version 20. La signification statistique a été fixé à p est inférieur à 0,05. 
Résultats : l'hématocrite, du taux d'hémoglobine, le fer sérique, capacité totale de fixation du fer, la saturation de la transferrine, 
l'albumine et l'albumine-globuline rapport entre les patients atteints de tuberculose ont été trouvés à être beaucoup plus faible 
alors que le taux de ferritine sérique et d'immunoglobuline humaine ont augmenté significativement (p  < 0,05) par rapport aux 




Conclusion : une réduction de l'hémoglobine, le fer sérique, capacité totale de fixation du fer et la saturation de la transferrine et 
la ferritine sérique en augmentation ainsi que le taux de protéines sériques modifié, se produisent dans l'infection par la 
tuberculose. 
Mots clés : Tuberculose, fer à repasser, protéine sérique 
INTRODUCTION                                                             
Tuberculosis (TB) is still a major concern of public health 
in Nigeria. Among the 22 high burden countries, Nigeria 
ranks eleventh [1]. Tuberculosis is primarily a pulmonary 
disease caused by Mycobacterium tuberculosis [2, 3]. It is 
an infectious disease which induces a state of chronic 
inflammation. The reference health facility for the 
diagnosis and treatment of tuberculosis in Cross River 
State, Southern Nigeria is Dr Lawrence Henshaw Memorial 
Hospital also called Infectious Disease Hospital located in 
the state capital, Calabar. This center is equipped to 
diagnose TB through microscopy, Gene Xpert, radiology 
and culture. The Directly Observed Therapy Short course 
(DOTS) program for the treatment of TB is fully 
implemented in this center. Iron is an essential 
micronutrient for all living organisms which plays a very 
crucial role in modulating the struggle for survival between 
mammals and pathogens. Its role is well known in 
metabolic processes such as cell respiration, growth and 
DNA synthesis [4]. It has been shown that iron overload 
promotes free radical induced tissue damage and organ 
failure, decreases immune protection and increases 
pathogen invasion. On the other hand, iron deficiency 
causes iron-deficiency anaemia with all its associated 
symptoms. An optimal level of iron is needed for natural 
immunity against the growth of pathogens [5]. 
Haematological abnormalities have been associated with 
tuberculosis infection. Decrease in packed cell volume and 
haemoglobin concentration and increase in erythrocyte 
sedimentation rate and relative plasma viscosity have been 
reported [6, 7]. It has also been reported that the majority of 
TB patients have significantly elevated level of antibodies 
against Mycobacterium tuberculosis in addition to acute 
phase response which involves release of plasma proteins 
as a consequence of inflammation [8, 9]. 
Hypoalbuminaemia, hyperproteinaemia and 
hyperglobulinaemia are findings associated with pulmonary 
tuberculosis [10]. There is paucity of information on iron 
parameters and serum protein levels in tuberculosis 
infection in our locality; hence this study was done to 
assess iron parameters and protein levels of patients with 
active tuberculosis in a reference health facility in Calabar, 
Nigeria. 
METHODS                                                                                                                                                                                           
A total of one hundred and eighty subjects were recruited 
for this study. This consisted of ninety tuberculosis patients 
of both gender aged between fifteen and sixty years, 
enrolled from Dr Lawrence Henshaw Memorial Hospital in 
Calabar, Cross River State, Nigeria. TB patients included 
newly diagnosed cases and those on anti-tuberculosis 
therapy. Anti-tuberculosis therapy under the directly 
observed therapy short course (DOTS) lasts for a period of 
six (6) months. Those patients on anti-tuberculosis therapy 
from day one up to less than two (2) months are in the 
intensive phase while two to six months constitute the 
continuation phase of treatment. Ninety apparently healthy 
individuals age and gender-matched who were negative for 
tuberculin (mantoux) test, selected from residents of 
Calabar metropolis were the control subjects. Ethical 
permission was given by the Cross River State Ministry of 
Health and all participants gave their consent. Packed cell 
volume and haemoglobin concentration was by 
microhaematocrit and Cyanmethaemoglobin methods 
respectively [11]. Serum iron (SI), total iron binding 
capacity (TIBC), total protein (TP) and albumin (ALB) 
were measured by colorimetric method with test kits 
manufactured by GIESSE Diagnostics, Italy and RANDOX 
Laboratories, United Kingdom. Serum ferritin (SF) was 
determined by enzyme linked immunosorbent assay 
(ELISA) using CALBIOTECH USA produced kit. 
Transferrin saturation (TS), globulin concentration (GLOB) 
and albumin-globulin ratio (ALB-GLOB) were derived by 
calculation. Student’s t-test was used to analyze data on 
SPSS version 20 software. Statistical significance was set 
at P-value less than 0.05. 
Consent: Informed consent was obtained from all 
participants in this study. 
 
Competing interest: No competing interest exists. 
 
Authors’ contributions: This work is a result of 
collaboration between all authors. Akpan PA designed the 
study and wrote the first draft of the manuscript. Okafor IM 
performed the statistical analysis. Anakebe S managed the 
literature searches. All authors were involved in the 
laboratory analysis; the final manuscript was read and 
approved by all authors.     
 
RESULTS                                                                                          
Demographic data of TB patients and controls is presented 
in figure 1. Tuberculosis patients consisted of 63 males and 
27 females while 60 males and 30 females served as control 
subjects. The TB patients as well as control were grouped 
into three based on age. Forty three (43) of the TB patients 
were aged 15-30 years with 36 and 11 aged 31-45 and 46-
60 years respectively. Similarly, controls were 38, 40 and 





FIGURE 1: DEMOGRAPHIC DATA OF TB PATIENTS 
AND CONTROL 
Table 1 shows iron parameters of TB patients and control 
subjects. The packed cell volume and haemoglobin of TB 
patients were observed to be significantly lower (p=0.004 
and 0.001) than values obtained for control. Similarly, 
serum iron, total iron binding capacity and transferrin 
saturation were significantly lower (p=0.001) for TB 
patients when compared to control.  Conversely, serum 
ferritin was significantly higher (p=0.001) for TB 
patients than their control. 
TABLE 1: IRON PARAMETERS OF TUBERCULOSIS 
PATIENTS AND CONTROL SUBJECTS 
Variable TB patients                  
(n=90) 
 Control  
  (n=90) 
P-
value 
    
Packed cell 
volume (L/L) 
0.37±0.06* 0.41±0.04  0.004 
Haemoglobin 
(g/L) 
1.04±0.16* 1.33±0.13  0.001 
Serum iron 
(µg/dl) 





187.10±37.00* 257.95±47.00  0.001 
Transferrin 
saturation (%) 
26.28±4.32* 41.62±8.13  0.001 
Serum ferritin 
(ng/ml) 
361.25±267.00* 82.40±53.84  0.001 
*: Significantly different from control subjects 
 
In table 2, the serum protein levels of tuberculosis 
patients and control are presented. The TB patients and 
their control had similar values (p=0.226) for total 
protein. While the albumin concentration was 
significantly lower (P=0.001) for the TB patients, the 
globulin level was significantly higher (p=0.016) when 
compared to control values. The albumin-globulin ratio 
was significantly lower (p=0.001) for TB patients than 
their control. 
 
TABLE 2: SERUM PROTEIN LEVELS OF 
TUBERCULOSIS PATIENTS AND CONTROL 
SUBJECTS 
Variable TB patients 
      n=90 
CONTROL 



















49.46±20.42* 38.78±21.20 0.016 
ALB-GLOB 
RATIO 
0.90±0.34* 1.32±0.44 0.001 
*: Significantly different from control subjects 
 
Figure 2a shows iron and protein levels of TB patients in 
different phases of treatment. Fifty two (52) of the ninety 
TB patients were in the intensive phase while the 
remaining thirty eight (38) were in the continuation phase 
of treatment. The serum iron, total iron binding capacity, 
transferrin saturation, total protein, ALB and GLOB did 
not change significantly between TB patients in both 
intensive and continuation treatment phases. However, 
the serum ferritin levels reduced significantly (p=0.001) 
from the intensive to the continuation treatment phase. In 
figure 2b, the PCV, HB and albumin-globulin ratio were 
observed to be comparable in both phases of treatment. 
 
 
FIGURE 2A: IRON AND PROTEIN LEVELS OF TB 
PATIENTS IN INTENSIVE AND CONTINUATION 



























FIGURE 2B: PCV, HB AND ALBUMIN-GLOBULIN RATIO OF 
TB PATIENTS IN INTENSIVE AND CONTINUATION PHASES 
OF TREATMENT 
DISCUSSION                                                                                                                       
This study has shown (table 1) that the packed cell 
volume and haemoglobin concentration of TB patients 
were significantly lower when compared to that of 
apparently healthy (control) subjects. Tuberculosis is a 
chronic ailment which could influence haemopoiesis 
leading to a reduction in erythropoiesis [12]. Reduced 
haemoglobin concentration below the reference range 
(11.0g/dl) which is termed anaemia, has been reported in 
tuberculosis infection [13, 7, 14]. This anaemia is 
classified as normocytic normochromic type showing 
features of anaemia of chronic disease and inflammation 
[15]. Other factors such as decrease in red cell survival 
and reduced erythroproietin response by the bone 
marrow erythroid cells are also known to cause anaemia 
in infections [12].  
The serum iron (SI) level of TB patients was 
significantly lower than the value obtained for control 
subjects. According to Dacie and Lewis [11], SI level is 
low in anaemia of chronic disease and infection. 
Tuberculosis being a chronic inflammatory condition, it 
interferes with iron metabolism resulting in a low serum 
iron. Similarly, a lower total iron binding capacity 
(TIBC) was observed for TB patients when compared to 
control values. TIBC has been reported to be lower than 
reference values in infections and particularly in anaemia 
of chronic disease [16, 11]. Low serum iron as well as 
total iron binding capacity in infection has been 
attributed to increased hepcidin production. Hepcidin is 
an acute phase protein which regulates the absorption of 
iron in the small intestine and its release from 
macrophages. In an inflammatory state such as 
tuberculosis, hepcidin level increases but its normal 
function is impaired resulting in low SI and TIBC levels 
[17, 18]. Furthermore, hepcidin induces certain 
alterations in the metabolism of iron like less iron 
absorption from the gastrointestinal tract as well as 
trapping of iron in macrophages [19]. Transferrin 
saturation (TS) of the TB patients was significantly lower 
than values obtained for control subjects. Since the TS is 
calculated from SI and TIBC, a low TS follows the 
pattern of the low SI and TIBC. The low values of these 
iron parameters imply that erythropoiesis is ineffective 
and this accounts for the anaemia observed in chronic 
disease and inflammation.  
 
The serum ferritin level of tuberculosis patients 
(361.25±267.00) was significantly higher (p=0.001) 
compared to control value (82.40±53.84). Serum ferritin 
is a valuable factor in the measurement of iron reserve of 
the body however it is a positive acute phase reactant 
protein which could be increased in tuberculosis 
infection due to inflammatory state [4]. As a reaction to 
injury, neutrophils and macrophages (local inflammatory 
cells) secrete several cytokines particularly interleukins 
(IL) 1, 6 and 8 as well as tissue necrotic factor alpha 
(TNFα) into the bloodstream. As a result, acute-phase 
reactants are produced by the liver in large amounts [20]. 
Also, the observed increase in ferritin level could be as a 
result of iron sequestration mechanism of the body 
during pathogen invasion. Iron supplementation which is 
the current practice in TB treatment, may be implicated 
in increased ferritin levels as the body withholds iron 
from the invading pathogen. It is therefore recommended 
that iron supplementation should be discouraged in the 
management of TB patients. 
In this study, the total protein levels of TB patients were 
similar to control values and also comparable to previous 
finding [21]. TB patients had a significantly lower 
albumin and a significantly higher globulin level 
(p<0.05) in comparison to control (table 2). Reduction in 
albumin level correlates with some reports [22, 23] and 
disagrees with increase in albumin reported in another 
study [24]. Low albumin may be due to inadequate 
protein intake while increased globulin concentration 
might be due to immune response by the body against the 
invading TB bacilli. The albumin/globulin ratio of the 
tuberculosis patients was found to be lower than that of 
apparently healthy subjects (control).  
It was observed that serum iron, TIBC, TS, albumin as 
well as globulin improved (though not significantly) in 
the continuation phase as compared to the intensive 
phase. On the other hand, serum ferritin reduced 
significantly (p<0.05) towards control values with 
progressive treatment. This could be attributed to 
adherence to anti-tuberculosis therapy under the DOTS 
program and the effectiveness of the anti-TB drugs in 
reversing the acute phase response. It also stands to 
reason that the body no longer withholds iron in the form 
of ferritin since the offending pathogen Mycobacterium 
tuberculosis is being cleared by the anti-TB drugs. 
Packed cell volume, haemoglobin and albumin-globulin 
ratio of TB patients were comparable for both phases of 
treatment. 
Conclusion: This study has shown that reduction in 
packed cell volume, haemoglobin, serum iron, total iron 
binding capacity, transferrin saturation and albumin and 
increase in serum ferritin and globulin concentration 
occur in active tuberculosis; also, iron parameters and 
protein levels improved as anti-tuberculosis therapy 
progressed. It is suggested that early diagnosis and 
initiation of anti-tuberculosis therapy and strict adherence 
will alleviate the changes in iron stores. 
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